The BroadOak Fund, LLC
RCT has partnered with BroadOak Capital Partners, LLC in the funding of The BroadOak Fund, LLC, an investment fund formed to provide growth capital to life sciences tools and service providers primarily through flexible debt structures. The BroadOak Fund is managed by BroadOak Capital Partners, LLC, a firm that actively invests in life sciences companies and has participated in over 25 investments in the public and private markets.
The BroadOak Fund’s investment approach includes:
- Providing growth capital to life sciences tools and service providers that have achieved a level of commercial success
- Focusing on the enterprises’ total value and to a lesser extent on specific collateral or profitability metrics
- Offering flexible investment alternatives to companies with specific growth capital needs
RCT Contact
Related Websites
Related News & Events
- 10.29.2025: BroadOak Capital Partners Adds More Than $200 Million of Permanent Capital
- 10.16.2025: Codis Launches as Global CDMO for Commercial Spray Drying and Amorphous Solid Dispersions
- 10.16.2025: Codis Raises Growth Capital to Expand Commercial Manufacturing; Welcomes 1315 Capital
- 1.24.2024: S2 Genomics Raises Series A Round Led by RCT and BroadOak
- 3.2.2023: Oligo Factory Opens New State-of-the-Art Oligo Manufacturing Facility with Funding from BroadOak and RCT
- 10.17.2022: BioTools Innovator Names GenNext Technologies The 2022 Winner GenNext Technologies Wins the $250,000 Grand Prize at the BioTools Innovator Capstone Event
- 7.21.2022: Kemp Proteins Secures $5M Growth Financing from BroadOak Capital Partners
- 7.6.2022: BioTools Innovator Announces Companies Selected for 2022 Accelerator Cohort
- 5.12.2022: RCT and Broad Oak Lead Major Investment in Biolog
- 7.29.2021: BioTools Innovator Selects Ten Leading Life Science Startups for Inaugural Accelerator Finalists to Compete in Grand Finals for an Opportunity to Win up to $200,000 in Non-Dilutive Funding
- 6.17.2021: Codex DNA Announces Pricing of Initial Public Offering
- 12.4.2012: BioCision Raises $2.5 Million Growth Financing to Support Continued Expansion
